ANSLY Ansell Ltd. $ANSLY Company Overview Stock Message

New Post Public Reply Private Reply Replies (0) Message Board
Rosner
ANSLY Ansell Ltd. $ANSLY Company Overview

Stock Message Board Recent Posts http://investorshangout.com/search?q=ANSLY&am...mp;yt0=Go!

Last Updated: 05/17/2015 16:40:04

Current Price and Quotes
Last Price 82.04
Previous Close 82.04 Open N/A
Daily Range N/A - N/A 52wk Range 64.99 - 88.31
Volume 0 Dividend 1.487
Average Vol (30d) 91 Net Dividend Yield 1.8125




Financials
Data is unavailable at this time. Please check this page later.


Recent News
Source
May 14, 2015 Ansell Announces New Cut Resistant Glove for Best-In-Class Protection, Performance, and Comfort PRWEB
Apr 2, 2015 Ansell Addresses Oil & Gas Workers' Top Frustrations With New ActivArmr® Glove Designed Specifically For The Upstream Environment PRWEB
Mar 10, 2015 Ansell Announces Third Annual Ansell Cares H.E.R.O. Nurse Service Award PRWEB
Mar 3, 2015 Ansell Introduces New HyFlex® Light Duty Oil Repellent Glove Featuring Grip and Oil Protection PRWEB
Feb 13, 2015 CEO Dr. Jackie Fairley To Be Interviewed Live On Iheart Radio/ Clear Channel Atlanta Studios 640 WGST AM's "Health Tech Talk Live" On February 14, 2015 [Market News Publishing (US)] Market News
Feb 13, 2015 Starpharma Holdings Limited CEO Dr. Jackie Fairley to Be Interviewed Live on iHeart Radio/ Clear Channel Atlanta Studios - 640 WGST AM's "Health Tech Talk Live" on February 14, 2015 Marketwired


ANSLY Ansell Ltd. Research DD Guide

Stock Message Board http://investorshangout.com/search?q=ANSLY&am...mp;yt0=Go!
Stock Quote http://www.otcmarkets.com/stock/ANSLY/quote
Stock Chart http://www.otcmarkets.com/stock/ANSLY/chart
Company Info http://www.otcmarkets.com/stock/ANSLY/company-info
Recent News http://www.otcmarkets.com/stock/ANSLY/news
Financials http://www.otcmarkets.com/stock/ANSLY/financials
Filings and Disclosure http://www.otcmarkets.com/stock/ANSLY/filings
Short Sales http://www.otcmarkets.com/stock/ANSLY/short-sales
Insider Disclosure http://www.otcmarkets.com/stock/ANSLY/insider-transactions
Research Reports http://www.otcmarkets.com/stock/ANSLY/research
Summary http://finance.yahoo.com/q?s=ANSLY
Historical Prices http://finance.yahoo.com/q/hp?s=ANSLY+Historical+Prices
Interactive Chart http://finance.yahoo.com/echarts?s=ANSLY
Basic Chart http://finance.yahoo.com/q/bc?s=ANSLY+Basic+Chart
Basic Tech. Analysis http://finance.yahoo.com/q/ta?s=ANSLY+Basic+Tech.+Analysis
Headlines http://finance.yahoo.com/q/h?s=ANSLY+Headlines
Press Releases http://finance.yahoo.com/q/p?s=ANSLY+Press+Releases
Company Profile http://finance.yahoo.com/q/pr?s=ANSLY+Profile
Key Statistics http://finance.yahoo.com/q/ks?s=ANSLY+Key+Statistics
Industry http://finance.yahoo.com/q/in?s=ANSLY+Industry
Major Holders http://finance.yahoo.com/q/mh?s=ANSLY+Major+Holders
Insider Transactions http://finance.yahoo.com/q/it?s=ANSLY+Insider+Transactions
Insider Roster http://finance.yahoo.com/q/ir?s=ANSLY+Insider+Roster
Income Statement http://finance.yahoo.com/q/is?s=ANSLY
Balance Sheet http://finance.yahoo.com/q/bs?s=ANSLY
Cash Flow http://finance.yahoo.com/q/cf?s=ANSLY+Cash+Flow&annual
Nasdaq http://www.nasdaq.com/symbol/ANSLY
Market Watch http://www.marketwatch.com/investing/stock/ANSLY
Bloomberg http://www.bloomberg.com/quote/ANSLY:US
Morningstar http://quotes.morningstar.com/stock/s?t=ANSLY
Bussinessweek http://investing.businessweek.com/research/st...cker=ANSLY
Barchart http://www.barchart.com/quotes/stocks/ANSLY
OTC Short Report http://otcshortreport.com/index.php?index=ANSLY
Investopedia http://www.investopedia.com/markets/stocks/ANSLY/?wa=0
Scroll down for more posts ▼

Top 10 Most Recent News Articles

Pacira BioSciences Faces Shareholder Revolt in M&A Deal

Updated Category News Views 4

A New Storm Brews Over Pacira's Sale to Viatris They say where there's smoke, there's fire, and it looks like Pacira BioSciences, Inc. (NASDAQ: PCRX) is running right into a bonfire thanks to their upcoming sale to Viatris Inc. On the face of it, shareholders are looking at a tidy $36.50 in cash per share, but not everyone's buying the deal as fair. Enter lawman Juan...

Continue Reading
AbbVie's SKYRIZI and RINVOQ Highlight IBD Control Advances

Updated Category News Views 11

A Deeper Look Into AbbVie's Latest Data Let's cut straight to the science, folks. At the recent American College of Gastroenterology 2026 Annual Scientific Meeting, AbbVie pulled the curtain on 22 fresh scientific abstracts that are really shaking things up in the field of inflammatory bowel disease (IBD) treatment. Data from the Phase 3 AFFIRM study shined especially...

Continue Reading
Southern Company Sparks Swift Power Restoration Post-Isaias

Updated Category News Views 17

Well, when Mother Nature decides to throw a tantrum, it takes seasoned hands and savvy tech to clean up the mess. That's exactly what Southern Company is doing after Hurricane Isaias wreaked havoc on the Southeast. With their electric utilities—Alabama Power, Georgia Power, and Mississippi Power—hitting the ground running, they've already restored power to a whopping...

Continue Reading
Phase I of 2026 Hong Kong Trade Shows Highlights Innovation

Updated Category News Views 15

Hong Kong Takes Center Stage in Global Commerce Flip through the economic landscape today, and you’ll spot Hong Kong, decked out in its best as a trade linchpin—with over 2,100 suppliers gathered under one roof. AsiaWorld-Expo is buzzing with the commencement of Phase I of the October 2026 Global Sources Hong Kong Shows. The theme's all about 'Connecting Global...

Continue Reading
LEGO Mashes Star Wars and Marvel for Fans' Delight

Updated Category News Views 14

A New Chapter in LEGO's Story Well, well, what do we have here? LEGO's throwing down the gauntlet. For the first time, they're asking fans to merge two colossal universes: Star Wars and Marvel. Talk about a brains-and-bricks bonanza! Announced at New York Comic Con with some star power from Kevin Smith, this LEGO Ideas challenge opens doors for fan creativity that might...

Continue Reading
Celltrion Unveils New Data on Infliximab: ACG 2026 Insight

Updated Category News Views 11

First Impressions: Celltrion's Latest Revelation Alright, let's jump straight into it. Celltrion USA is flaunting its latest findings on ZYMFENTRA® (infliximab-dyyb) for Crohn's disease and ulcerative colitis right at the American College of Gastroenterology's (ACG) grand event in 2026. If you've been watching the healthcare sector, this is significant news. It's got all...

Continue Reading
NARUTO Card Game Set for June 2027 Global Launch

Updated Category News Views 14

Mark Your Calendars: Global Launch June 2027 They're rolling out a red carpet for nostalgia here, I tell ya! At the New York Comic Con, BANDAI announced a worldwide launch for the NARUTO CARD GAME in June 2027. We'll see pre-built decks starring your favorite shinobi and a mad sprint to collect with the new booster packs. Feels sort of like they’re summoning a jutsu...

Continue Reading
AI Drives Major Time Savings in Endoscopy Tech

Updated Category News Views 12

AI in Endoscopy: Game-Changer or Gimmick? Stumbling across AnX Robotica's latest pitch about their NaviCam ProScan AI workflow, one can't help but feel a mix of curiosity and skepticism. With the stakes in medical tech sky-high, they've fired off some impressive stats that grab attention. We're talking about cutting small-bowel capsule review times by a whopping...

Continue Reading
2026 Community Impact Week: Slam Dunk for Community Unity

Updated Category News Views 8

Alright, if you're looking for a story that gives you those warm fuzzy feelings while wrapping you in a big sports hug, here it is. Imagine this: you've got basketball legends, world-class athletes, and a corporate heavyweight, all huddling up to make a community impact that's more than just warm air. Hoops, Hope, and High Fives The NBA Cares x Sands Cares Community...

Continue Reading
Sebela Pharma's Tegoprazan Posts Strong Phase 3 Data

Updated Category News Views 9

Spotlight on Tegoprazan: A New Player on the GERD Field Sometimes, a pharma company turns heads with data that speaks for itself. This time, Sebela Pharmaceuticals is doing just that with Tegoprazan's phase 3 results, shining a light on an area overlooked for too long: non-erosive reflux disease (NERD). Showing promise in its latest trials, Tegoprazan is muscling into the...

Continue Reading

Top 5 Most Recently Viewed Articles

Transforming Logistics: eHub and Osa Commerce Strategic Alliance

Updated Category News Views 127

Revolutionizing Logistics and Fulfillment eHub and Osa Commerce have embarked on an exciting journey together, aiming to transform the logistics and fulfillment landscape. This strategic partnership focuses on enhancing the way businesses manage their supply chain and fulfillment processes, offering integrated solutions that promise efficiency and scalability. A...

Continue Reading
Investing Insights: Top Consumer Stocks to Watch Now

Updated Category News Views 227

Exploring Undervalued Consumer Stocks The consumer discretionary sector often provides unique investment opportunities, especially during periods when stocks are regarded as oversold. Monitoring key indicators like the Relative Strength Index (RSI) can help guide investors toward potential gains. Stocks with an RSI below 30 may be considered undervalued and represent...

Continue Reading
Discover the Unique Urban Sanctuary: The Standard Singapore

Updated Category News Views 234

A New Era Begins with The Standard Singapore The brand's fifth Asia Pacific property has officially welcomed guests into its urban sanctuary in the heart of the city. The Standard Singapore is poised to redefine luxury experiences, following the successful launches of The Standard, Hua Hin and The Standard, Bangkok Mahanakhon. Exceptional Accommodations This stylish...

Continue Reading
Aluminum Refractory Market to Hit $2.73B by 2031

Updated Category News Views 16

Riding the Aluminum Refractory Wave to 2031 Look, when you want to throw some cash in a market that's gaining steam, aluminum refractory materials might not be your first pick. But here's the thing: it's charging ahead to a cool $2.73 billion by 2031. And if you're keeping tabs on the likes of RHI Magnesita and Calderys, this is a sector that deserves a once-over. What...

Continue Reading
Lecomely Unveils Revolutionary AirEdge A3 Multi-Styler for All

Updated Category News Views 556

Lecomely Unveils the Innovative AirEdge A3 Multi-Styler Lecomely, a trailblazer in the beauty industry, is transforming personal care with its latest introduction, the Lecomely AirEdge A3 Multi-styler. This new styling tool is engineered to provide precision styling with a focus on maintaining hair health. Combining advanced technology and ergonomic design, it allows...

Continue Reading